In this work we demonstrate early response to STING + TLR9 combination immunotherapy in an immunologically cold 4T1 breast cancer (BC) murine tumor model with multiplexed dynamic molecular imaging with surface-enhanced Raman spectroscopy (SERS). This evidence concerns the gene TLR9 and neoplasm.